Pricing Log in Create free account

ICON PLC (ICLR) vs QIAGEN N.V. (QGEN)

ICON PLC and QIAGEN N.V. are both Diagnostics & Research companies. ICON PLC is the larger, with a market value of $13.5B against $9.5B — 1.4× the size. QIAGEN N.V. trades at the lower P/E: 23.6× against 254×. ICON PLC grew revenue faster over the last twelve months: 3.26% against 2.96%. QIAGEN N.V. has the higher net margin (19.5% vs 0.51%) and the higher return on invested capital (6.62% vs 1.57%). Across the 22 metrics below, QIAGEN N.V. leads on 14 and ICON PLC on 8.

Valuation

Metric ICLR QGEN Diagnostics & Research median
P/E 254.23 23.64 35.56
P/S 1.58 4.53 4.37
P/B 1.39 2.83 3.06
Price to free cash flow 14.80 21.60 35.76
EV/EBITDA 23.30 15.93 24.35
EV/Sales 1.87 4.94 5.51
Earnings yield 0.39% 4.23% (1.89%)
Free cash flow yield 6.76% 4.63% (0.15%)

Profitability

Metric ICLR QGEN Diagnostics & Research median
Gross margin 23.91% 62.20% 50.89%
Operating margin 3.57% 21.21% (8.57%)
Net margin 0.51% 19.49% (6.37%)
Free cash flow margin 10.66% 20.98% 0.00%
Return on equity 0.45% 11.93% (2.92%)
Return on assets 0.26% 6.99% (6.71%)
Return on invested capital 1.57% 6.62% 0.00%

Growth

Metric ICLR QGEN Diagnostics & Research median
Revenue growth (TTM) 3.26% 2.96% 7.69%
EPS growth (last fiscal year) (69.57%) 398.07% 25.92%
Revenue growth, 5-year CAGR 24.15% 2.25% 7.40%
Net income growth, 5-year CAGR (7.15%) 3.42% 0.00%

Health

Metric ICLR QGEN Diagnostics & Research median
Debt to equity 0.36 0.49 0.11
Current ratio 0.95 2.85 2.02
Net debt to EBITDA 3.34 0.84 0.70

Dividend

Metric ICLR QGEN Diagnostics & Research median
Dividend yield — 0.76% 0.66%
Payout ratio — 0.18 0.20

Size

Metric ICLR QGEN Diagnostics & Research median
Market cap 13.51b 9.51b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack